Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Cortical Stimulators Pipeline Market Report Overview

The cortical stimulator is a medical device used to revive neural activity in the nervous system of critical patients by delivering an electrical shock using leads and electrode arrays implanted on the surface of the brain to induce brain activity.

The cortical stimulators pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·        United States

·        Europe

·        China

·        United Kingdom

Key Regulatory Paths ·        PMA

·        CE

·        NMPA

·        510(k)

Leading Companies ·        Ab Medica Spa

·        Aleva Neurotherapeutics SA

·        Cadence Neuroscience Inc

·        Catalan Institute of Nanoscience and Nanotechnology

·        Clinatec

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cortical Stimulators Pipeline Market Segmentation by Territories

A few of the key territories associated with the cortical stimulators pipeline market are the United States, Europe, China, and Saudi Arabia. As of October 2024, the US had the highest number of cortical stimulators pipeline products.

Cortical Stimulators Pipeline Market Analysis by Territories, 2024 (%)

Cortical Stimulators Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Cortical Stimulators Pipeline Market

Download a Free Report Sample

Cortical Stimulators Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the cortical stimulators pipeline products market are PMA, CE, NMPA, and 510(k). As of October 2024, PMA was the most followed pathway for pipeline products in the cortical stimulators market.

Cortical Stimulators Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Cortical Stimulators Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Cortical Stimulators Pipeline Market

Download a Free Report Sample

Cortical Stimulators Pipeline Market – Competitive Landscape

A few of the key companies associated with the cortical stimulators pipeline market are Ab Medica Spa, Aleva Neurotherapeutics SA, Cadence Neuroscience Inc, Catalan Institute of Nanoscience and Nanotechnology, and Clinatec among others.

Ab Medica Spa: AB Medica SpA (AB Medica) is a medical technology company that offers robotic solutions. The company offers products such as da vinci, cyberknife , lightstrike, mako, focal one and aquabeam. The CyberKnifeis a robotic system used for radiosurgery and stereotactic radiotherapy that allows the use of clinical protocols.

Aleva Neurotherapeutics SA: Aleva Neurotherapeutics SA (Aleva) is a medical devices company. The company’s products include directSTIM deep brain stimulation systems for the treatment of Parkinson’s disease and essential tremors. directSTIM deep brain stimulation system helps to improve therapeutic benefits minimise side effects, decrease the number of non-responding patients, reduce revisions. Its products are used by neurologists and neurosurgeons in the treatment of Parkinson’s disease and essential tremor. Its technology allows to manufacture micro-smooth surfaces and electrode shapes specifically designed for the brain. Aleva is headquartered in Lausanne, Waadt, Switzerland.

Cortical Stimulators Pipeline Market Analysis by Companies, As of October 2024
Cortical Stimulators Pipeline Market Analysis by Companies, As of October 2024Buy the Full Report for More Company Insights into the Cortical Stimulators Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Cortical Stimulators Pipeline Market Territories Outlook (2024)

  • United States
  • Europe
  • China
  • United Kingdom

Cortical Stimulators Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • NMPA
  • 510(k)

Scope

The report provides:

  • Extensive coverage of the cortical stimulators under development.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of cortical stimulators and list all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to approved / issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of Cortical Stimulators under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.

ab medica spa
Aleva Neurotherapeutics SA
Cadence Neuroscience Inc
Catalan Institute of Nanoscience and Nanotechnology
Clinatec
Columbia Engineering
Cortigent Inc
Cortivis
EPIC Neuro Inc
Hangzhou Jialiang Medical Technology Co Ltd
Johns Hopkins University
Koninklijke Philips NV
Medtronic
NeuroPace Inc
NYU Langone Health System
Polytechnique Montreal
Precisis GmbH
St. Jude Medical LLC
University of California Los Angeles
University of Wisconsin Madison
WISE s.r.l.

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Cortical Stimulators Overview

3 Products under Development

3.1 Cortical Stimulators – Pipeline Products by Stage of Development

3.2 Cortical Stimulators – Pipeline Products by Territory

3.3 Cortical Stimulators – Pipeline Products by Regulatory Path

3.4 Cortical Stimulators – Pipeline Products by Estimated Approval Date

3.5 Cortical Stimulators – Ongoing Clinical Trials

4 Cortical Stimulators – Pipeline Products under Development by Companies

4.1 Cortical Stimulators Companies – Pipeline Products by Stage of Development

4.2 Cortical Stimulators – Pipeline Products by Stage of Development

5 Cortical Stimulators Companies and Product Overview

5.1 ab medica spa Company Overview

5.1.1 ab medica spa Pipeline Products & Ongoing Clinical Trials Overview

5.2 Aleva Neurotherapeutics SA Company Overview

5.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview

5.3 Cadence Neuroscience Inc Company Overview

5.3.1 Cadence Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 Catalan Institute of Nanoscience and Nanotechnology Company Overview

5.4.1 Catalan Institute of Nanoscience and Nanotechnology Pipeline Products & Ongoing Clinical Trials Overview

5.5 Clinatec Company Overview

5.5.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview

5.6 Columbia Engineering Company Overview

5.6.1 Columbia Engineering Pipeline Products & Ongoing Clinical Trials Overview

5.7 Cortigent Inc Company Overview

5.7.1 Cortigent Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 Cortivis Company Overview

5.8.1 Cortivis Pipeline Products & Ongoing Clinical Trials Overview

5.9 EPIC Neuro Inc Company Overview

5.9.1 EPIC Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 Hangzhou Jialiang Medical Technology Co Ltd Company Overview

5.10.1 Hangzhou Jialiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.11 Johns Hopkins University Company Overview

5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

5.12 Koninklijke Philips NV Company Overview

5.12.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview

5.13 Medtronic Company Overview

5.13.1 Medtronic Pipeline Products & Ongoing Clinical Trials Overview

5.14 NeuroPace Inc Company Overview

5.14.1 NeuroPace Inc Pipeline Products & Ongoing Clinical Trials Overview

5.15 NYU Langone Health System Company Overview

5.15.1 NYU Langone Health System Pipeline Products & Ongoing Clinical Trials Overview

5.16 Polytechnique Montreal Company Overview

5.16.1 Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview

5.17 Precisis GmbH Company Overview

5.17.1 Precisis GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.18 St. Jude Medical LLC Company Overview

5.18.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.19 University of California Los Angeles Company Overview

5.19.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

5.20 University of Wisconsin Madison Company Overview

5.20.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

5.21 WISE s.r.l. Company Overview

5.21.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview

6 Cortical Stimulators- Recent Developments

6.1 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance

6.2 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors

6.3 Feb 22, 2024: Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call

6.4 Dec 21, 2023: NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study

6.5 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook

6.6 Oct 16, 2023: EASEE: The Innovation in Epilepsy Treatment – The Groundbreaking Implant in the Spotlight of Medtech Outlook

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Cortical Stimulators – Pipeline Products by Stage of Development

Cortical Stimulators – Pipeline Products by Territory

Cortical Stimulators – Pipeline Products by Regulatory Path

Cortical Stimulators – Pipeline Products by Estimated Approval Date

Cortical Stimulators – Ongoing Clinical Trials

Cortical Stimulators Companies – Pipeline Products by Stage of Development

Cortical Stimulators – Pipeline Products by Stage of Development

ab medica spa Pipeline Products & Ongoing Clinical Trials Overview

Cyberbrain – Product Status

Cyberbrain – Product Description

Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview

cortiSTIM – Product Status

cortiSTIM – Product Description

Cadence Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

Next Generation Implantable Device – Epilepsy – Product Status

Next Generation Implantable Device – Epilepsy – Product Description

Catalan Institute of Nanoscience and Nanotechnology Pipeline Products & Ongoing Clinical Trials Overview

Neuroprosthetic Cortical Device – Product Status

Neuroprosthetic Cortical Device – Product Description

Clinatec Pipeline Products & Ongoing Clinical Trials Overview

Wimagine Implant – Product Status

Wimagine Implant – Product Description

Clinatec – Ongoing Clinical Trials Overview

Wimagine Implant – Brain Controlled Spinal Cord Stimulation in Participants with Cervical Spinal Cord Injury for Upper Limb Rehabilitation (UP2)

Wimagine Implant – Brain Controlled Spinal Cord Stimulation in Participants with Spinal Cord Injury for Lower Limb Rehabilitation

Columbia Engineering Pipeline Products & Ongoing Clinical Trials Overview

MTA System – Product Status

MTA System – Product Description

Cortigent Inc Pipeline Products & Ongoing Clinical Trials Overview

Stroke Recovery System – Product Status

Stroke Recovery System – Product Description

Cortivis Pipeline Products & Ongoing Clinical Trials Overview

Cortical Visual Neuroprosthesis Implant – Product Status

Cortical Visual Neuroprosthesis Implant – Product Description

Cortivis – Ongoing Clinical Trials Overview

Cortical Visual Neuroprosthesis Implant – Pilot Study for the Development of a Cortical Visual Neuroprosthesis for the Blind Based on Intracortical Microelectrodes

EPIC Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview

EPIC (Externally Powered Implantable Coil) Brain Stimulator – Product Status

EPIC (Externally Powered Implantable Coil) Brain Stimulator – Product Description

Hangzhou Jialiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Epilcure Implantable Closed-Loop Self-Responsive Neurostimulation System – Product Status

Epilcure Implantable Closed-Loop Self-Responsive Neurostimulation System – Product Description

Implantable Closed-Loop Self-Responsive Neurostimulation System – Depression – Product Status

Implantable Closed-Loop Self-Responsive Neurostimulation System – Depression – Product Description

Implantable Closed-Loop Self-Responsive Neurostimulation System – Parkinson’s Disease – Product Status

Implantable Closed-Loop Self-Responsive Neurostimulation System – Parkinson’s Disease – Product Description

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

Bidirectional Cortical Neuroprosthetic System – Product Status

Bidirectional Cortical Neuroprosthetic System – Product Description

Johns Hopkins University – Ongoing Clinical Trials Overview

Bidirectional Cortical Neuroprosthetic System – Investigation on the Bidirectional Cortical Neuroprosthetic System

Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview

GTEN 100 Neuromodulation Device – Product Status

GTEN 100 Neuromodulation Device – Product Description

Medtronic Pipeline Products & Ongoing Clinical Trials Overview

Implantable Neural Device – Product Status

Implantable Neural Device – Product Description

NeuroPace Inc Pipeline Products & Ongoing Clinical Trials Overview

NeuroPace RNS System – Adolescents – Product Status

NeuroPace RNS System – Adolescents – Product Description

NeuroPace RNS System – Idiopathic Generalized Epilepsy – Product Status

NeuroPace RNS System – Idiopathic Generalized Epilepsy – Product Description

NeuroPace RNS System – Lennox Gastaut Syndrome – Product Status

NeuroPace RNS System – Lennox Gastaut Syndrome – Product Description

NeuroPace Inc – Ongoing Clinical Trials Overview

NeuroPace RNS System – Idiopathic Generalized Epilepsy – Mapping Algorithmic State Space in the Human Brain

NeuroPace RNS System – Idiopathic Generalized Epilepsy – RNS System NAUTILUS Study (NAUTILUS)

NYU Langone Health System Pipeline Products & Ongoing Clinical Trials Overview

Brain Implant – Chronic Pain – Product Status

Brain Implant – Chronic Pain – Product Description

Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview

Intra-Cortical Visual Prosthesis – Product Status

Intra-Cortical Visual Prosthesis – Product Description

Microelectrode Array – Cortical Stimulation – Product Status

Microelectrode Array – Cortical Stimulation – Product Description

Precisis GmbH Pipeline Products & Ongoing Clinical Trials Overview

EASEE Next Generation System – Product Status

EASEE Next Generation System – Product Description

EASEE System – Epilepsy – Product Status

EASEE System – Epilepsy – Product Description

EASEE System – Major Depressive Disorder – Product Status

EASEE System – Major Depressive Disorder – Product Description

EASEE System – Stroke – Product Status

EASEE System – Stroke – Product Description

Precisis GmbH – Ongoing Clinical Trials Overview

EASEE System – Epilepsy – EASEE4YOU – A Clinical Investigation of the Safety and Efficacy of Transcranial Focal Cortex Stimulation with the EASEE System for the Treatment of Medically Refractory Focal Epilepsy in Young Patients, Aged 12 to 17 Years

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

Renova-DT Cortical Stimulation System – Product Status

Renova-DT Cortical Stimulation System – Product Description

Renova-ST Cortical Stimulation System – Product Status

Renova-ST Cortical Stimulation System – Product Description

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

Brain Prosthetic Device – Product Status

Brain Prosthetic Device – Product Description

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

Brain-Computer Microelectrode Interface – Product Status

Brain-Computer Microelectrode Interface – Product Description

WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview

Cortical Grid – Product Status

Cortical Grid – Product Description

Glossary

Figures

Cortical Stimulators – Pipeline Products by Stage of Development

Cortical Stimulators – Pipeline Products by Territory

Cortical Stimulators – Pipeline Products by Regulatory Path

Cortical Stimulators – Pipeline Products by Estimated Approval Date

Cortical Stimulators – Ongoing Clinical Trials

Frequently asked questions

Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.